Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fatty acid translocase (CD36) is a membrane-associated transporter protein with high affinity for long-chain fatty acids. It plays a crucial role in facilitating the uptake and transport of these fatty acids into cells—particularly skeletal muscle and heart—and across mitochondrial membranes where they undergo β‑oxidation to produce energy. The presence and function of FAT/CD36 on both plasma and mitochondrial membranes are essential for efficient cellular fat utilization, especially during periods of increased metabolic demand such as exercise. Experimental inhibition with sulfo-N-succimidyl oleate dramatically reduces palmitate oxidation, highlighting its central role in regulating lipid-derived energy production. Alterations or deficiencies in FAT/CD36 expression have been linked to metabolic diseases including insulin resistance, obesity, cardiovascular disease, and may also influence tumor cell metabolism due to its impact on cellular fuel supply.
Inhibition of CD36 reduces mitochondrial uptake and oxidation of long-chain fatty acids by blocking their transport across the membrane
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fatty acid translocase (CD36) (CD36).